The agency said a chemical structure analysis confirmed that it is a new synthetic drug that has been reported for the first ...
Biogen expects Leqembi and new rare disease and depression treatments to help offset revenue lost from multiple sclerosis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback